| 产品名称: | Escherichia coli bacteriophage phi V-1 |
|---|---|
| 商品货号: | TS146834 |
| Deposited As: | phi V-1 |
| Strain Designations: | phi V-1 |
| Host Organism: | Escherichia coli strain C-3000 (ATCC 15597) |
| Application: | Characterization |
| Isolation: | Measles vaccine |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®: | no |
| Type Strain: | no |
| Comments: | Risk |
| Medium: | ATCC® Medium 271: Escherichia medium |
| Growth Conditions: | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor: | AG Lochhead |
| References: | Milstien JB, et al. Bacteriophages in live virus vaccines: lack of evidence for effects on the genome of rhesus monkeys. Science 197: 469-470, 1977. PubMed: 406673 Petricciani JC, et al. Bacteriophages, vaccines, and people: an assessment of risk. Proc. Soc. Exp. Biol. Med. 158: 378-382, 1978. PubMed: 98771 Haselkorn R, et al. Characteristics of bacteriophage phiV-1 isolated from live virus vaccines. Proc. Soc. Exp. Biol. Med. 158: 383-387, 1978. PubMed: 684007 |